The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Because neurodegenerative diseases, heart attacks, infarctions, liver disease, lung cancer, you know, leukemia, I mean, we're talking about tuning up humans every so often, giving them these growth factors they need, possibly replacing some cells that are lost, and extending the lifespan.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
And so, if you think about it in the context of neurodegenerative diseases, Parkinson's disease, Alzheimer's disease, this could be a game changer.